Improving the large scale purification of the HIV microbicide, griffithsin

BMC Biotechnology

Joshua L Fuqua²  Valentine Wanga¹  Kenneth E Palmer² 

[1] Institute for Health Metrics and Evaluation, University of Washington, 2301 5th Ave, Suite 600, Seattle, WA, USA

[2] University of Louisville School of Medicine, James Graham Brown Cancer Center, 529 S Jackson Street, Louisville 40202, KY, USA

关键词: HIV;    Microbicide;    Bentonite;    N. benthamiana;    Protein purification;    Tobacco mosaic virus;    Griffithsin;   

Others  :  1134512
DOI  :  10.1186/s12896-015-0120-5

 received in 2014-10-21, accepted in 2015-01-30,  发布年份 2015

【 摘 要 】

Background

Griffithsin is a broad spectrum antiviral lectin that inhibits viral entry and maturation processes through binding clusters of oligomannose glycans on viral envelope glycoproteins. An efficient, scaleable manufacturing process for griffithsin active pharmaceutical ingredient (API) is essential for particularly cost-sensitive products such as griffithsin -based topical microbicides for HIV-1 prevention in resource poor settings. Our previously published purification method used ceramic filtration followed by two chromatography steps, resulting in a protein recovery of 30%. Our objective was to develop a scalable purification method for griffithsin expressed in Nicotiana benthamiana plants that would increase yield, reduce production costs, and simplify manufacturing techniques. Considering the future need to transfer griffithsin manufacturing technology to resource poor areas, we chose to focus modifying the purification process, paying particular attention to introducing simple, low-cost, and scalable procedures such as use of temperature, pH, ion concentration, and filtration to enhance product recovery.

Results

We achieved >99% pure griffithsin API by generating the initial green juice extract in pH 4 buffer, heating the extract to 55°C, incubating overnight with a bentonite MgCl₂ mixture, and final purification with Capto™ multimodal chromatography. Griffithsin extracted with this protocol maintains activity comparable to griffithsin purified by the previously published method and we are able to recover a substantially higher yield: 88 ± 5% of griffithsin from the initial extract. The method was scaled to produce gram quantities of griffithsin with high yields, low endotoxin levels, and low purification costs maintained.

Conclusions

The methodology developed to purify griffithsin introduces and develops multiple tools for purification of recombinant proteins from plants at an industrial scale. These tools allow for robust cost-effective production and purification of griffithsin. The methodology can be readily scaled to the bench top or industry and process components can be used for purification of additional proteins based on biophysical characteristics.

【 授权许可】

   
2015 Fuqua et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Mori T, O’Keefe BR, Sowder RC 2nd, Bringans S, Gardella R, Berg S, et al.: Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp. J Biol Chem 2005, 280(10):9345-53.
• [2]Nixon B, Stefanidou M, Mesquita PM, Fakioglu E, Segarra T, Rohan L, et al.: Griffithsin Protects Mice from Genital Herpes by Preventing Cell-to-Cell Spread. J Virol 2013, 87(11):6257-69.
• [3]Emau P, Tian B, O’Keefe BR, Mori T, McMahon JB, Palmer KE, et al.: Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide. J Med Primatol 2007, 36(4–5):244-53.
• [4]O’Keefe BR, Vojdani F, Buffa V, Shattock RJ, Montefiori DC, Bakke J, et al.: Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component. Proc Natl Acad Sci U S A 2009, 106(15):6099-104.
• [5]Giomarelli B, Schumacher KM, Taylor TE, Sowder RC 2nd, Hartley JL, McMahon JB, et al.: Recombinant production of anti-HIV protein, griffithsin, by auto-induction in a fermentor culture. Protein Expr Purif 2006, 47(1):194-202.
• [6]Kouokam JC, Huskens D, Schols D, Johannemann A, Riedell SK, Walter W, et al.: Investigation of griffithsin’s interactions with human cells confirms its outstanding safety and efficacy profile as a microbicide candidate. PLoS One 2011, 6(8):e22635.
• [7]Moulaei T, Shenoy SR, Giomarelli B, Thomas C, McMahon JB, Dauter Z, et al.: Monomerization of viral entry inhibitor griffithsin elucidates the relationship between multivalent binding to carbohydrates and anti-HIV activity. Structure 2010, 18(9):1104-15.
• [8]Ziolkowska NE, Shenoy SR, O’Keefe BR, McMahon JB, Palmer KE, Dwek RA, et al.: Crystallographic, thermodynamic, and molecular modeling studies of the mode of binding of oligosaccharides to the potent antiviral protein griffithsin. Proteins 2007, 67(3):661-70.
• [9]Brakke MK, Van Pelt N: Influence of bentonite, magnesium, and polyamines on degradation and aggregation of tobacco mosaic virus. Virology 1969, 39(3):516-33.
• [10]O’Keefe BR, Giomarelli B, Barnard DL, Shenoy SR, Chan PK, McMahon JB, et al.: Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae. J Virol 2010, 84(5):2511-21.
• [11]Takebe Y, Saucedo CJ, Lund G, Uenishi R, Hase S, Tsuchiura T, et al.: Antiviral Lectins from Red and Blue-Green Algae Show Potent In Vitro and In Vivo Activity against Hepatitis C Virus. PLoS One 2013, 8(5):e64449.
• [12]Ishag HZ, Li C, Huang L, Sun MX, Wang F, Ni B, et al.: Griffithsin inhibits Japanese encephalitis virus infection in vitro and in vivo. Arch Virol 2013, 158(2):349-58.
• [13]Hoorelbeke B, Xue J, Liwang PJ, Balzarini J: Role of the Carbohydrate-Binding Sites of Griffithsin in the Prevention of DC-SIGN-Mediated Capture and Transmission of HIV-1. PLoS One 2013, 8(5):e64132.
• [14]Meuleman P, Albecka A, Belouzard S, Vercauteren K, Verhoye L, Wychowski C, et al.: Griffithsin has antiviral activity against hepatitis C virus. Antimicrob Agents Chemother 2011, 55(11):5159-67.
• [15]Xue J, Gao Y, Hoorelbeke B, Kagiampakis I, Zhao B, Demeler B, et al.: The role of individual carbohydrate-binding sites in the function of the potent anti-HIV lectin griffithsin. Mol Pharm 2012, 9(9):2613-25.
• [16]Barton C, Kouokam JC, Lasnik AB, Foreman O, Cambon A, Brock G, et al.: Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models. Antimicrob Agents Chemother 2014, 58(1):120-7.
• [17]Sherwood JL, Fulton RW: The specific involvement of coat protein in tobacco mosaic virus cross protection. Virology 1982, 119(1):150-8.
• [18]Powell CA: The effect of cations on the alkaline dissociation of tobacco mosaic virus. Virology 1975, 64(1):75-85.